Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Molecular imaging of tumor hypoxia with positron emission tomography.

Kelada OJ, Carlson DJ.

Radiat Res. 2014 Apr;181(4):335-49. doi: 10.1667/RR13590.1. Epub 2014 Mar 27. Review.

PMID:
24673257
[PubMed - indexed for MEDLINE]
2.

Radiolabelled agents for PET imaging of tumor hypoxia.

Kurihara H, Honda N, Kono Y, Arai Y.

Curr Med Chem. 2012;19(20):3282-9. Review.

PMID:
22664246
[PubMed - indexed for MEDLINE]
3.

Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.

Wijsman R, Kaanders JH, Oyen WJ, Bussink J.

Q J Nucl Med Mol Imaging. 2013 Sep;57(3):244-56. Review.

PMID:
24045621
[PubMed - indexed for MEDLINE]
Free Article
4.

Hypoxia PET/CT imaging: implications for radiation oncology.

Arabi M, Piert M.

Q J Nucl Med Mol Imaging. 2010 Oct;54(5):500-9. Review.

PMID:
20927017
[PubMed - indexed for MEDLINE]
Free Article
5.

Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Holland JP, Lewis JS, Dehdashti F.

Q J Nucl Med Mol Imaging. 2009 Apr;53(2):193-200. Review.

PMID:
19293767
[PubMed - indexed for MEDLINE]
Free Article
6.

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1171-82.

PMID:
11240261
[PubMed - indexed for MEDLINE]
7.

Positron emission tomography imaging of cancer biology: current status and future prospects.

Chen K, Chen X.

Semin Oncol. 2011 Feb;38(1):70-86. doi: 10.1053/j.seminoncol.2010.11.005. Review.

PMID:
21362517
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Imaging of hypoxia using PET and MRI.

Gaertner FC, Souvatzoglou M, Brix G, Beer AJ.

Curr Pharm Biotechnol. 2012 Mar;13(4):552-70. Review.

PMID:
22214501
[PubMed - indexed for MEDLINE]
10.

PET and PET/CT studies of tumor tissue oxygenation.

Krause BJ, Beck R, Souvatzoglou M, Piert M.

Q J Nucl Med Mol Imaging. 2006 Mar;50(1):28-43. Review.

PMID:
16557202
[PubMed - indexed for MEDLINE]
Free Article
11.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
[PubMed - indexed for MEDLINE]
12.

Molecular imaging of hypoxia with radiolabelled agents.

Mees G, Dierckx R, Vangestel C, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1674-86. doi: 10.1007/s00259-009-1195-9. Epub 2009 Jun 30. Review.

PMID:
19565239
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.

PMID:
23074393
[PubMed]
Free PMC Article
14.

Recent advances on radionuclide labeled hypoxia-imaging agents.

Li Z, Chu T.

Curr Pharm Des. 2012;18(8):1084-97. Review.

PMID:
22272826
[PubMed - indexed for MEDLINE]
15.

Review of positron emission tomography tracers for imaging of tumor hypoxia.

Imam SK.

Cancer Biother Radiopharm. 2010 Jun;25(3):365-74. doi: 10.1089/cbr.2009.0740. Review.

PMID:
20578843
[PubMed - indexed for MEDLINE]
16.

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M.

J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033. Epub 2013 Apr 14.

PMID:
23589026
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Monitoring response to treatment in patients utilizing PET.

Avril NE, Weber WA.

Radiol Clin North Am. 2005 Jan;43(1):189-204. Review.

PMID:
15693656
[PubMed - indexed for MEDLINE]
18.

Implementation of hypoxia PET imaging in radiation therapy planning.

Geets X, Grégoire V, Lee JA.

Q J Nucl Med Mol Imaging. 2013 Sep;57(3):271-82. Review.

PMID:
24045623
[PubMed - indexed for MEDLINE]
Free Article
19.

Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.

Jacobson O, Chen X.

Pharmacol Rev. 2013 Sep 24;65(4):1214-56. doi: 10.1124/pr.113.007625. Print 2013. Review.

PMID:
24064460
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Dietz DW, Dehdashti F, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, Ritter J, Lewis JS, Welch MJ, Siegel BA.

Dis Colon Rectum. 2008 Nov;51(11):1641-8. doi: 10.1007/s10350-008-9420-3. Epub 2008 Aug 6.

PMID:
18682881
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk